Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;192(6):3163-3167.
doi: 10.1007/s11845-023-03351-4. Epub 2023 Mar 27.

Adherence of patients with age-related macular degeneration to AREDS 2-recommended nutritional supplements

Ammr Alghamdi  1   2 , David Keegan  1 , Paul Connell  1 , Ian Dooley  1 , Louise O'Toole  3
Affiliations

Adherence of patients with age-related macular degeneration to AREDS 2-recommended nutritional supplements

Ammr Alghamdi et al. Ir J Med Sci. 2023 Dec.

Abstract

Background: The Age-Related Eye Disease Study 2 (AREDS 2) proved the benefit of vitamin and mineral supplementation in preventing advanced age-related macular degeneration (AMD). AREDS 2 supplements are indicated for patients with either bilateral intermediate AMD (AREDS category 3) or unilateral neovascular AMD (AREDS category 4).

Aims: The aims of this telephone survey were to identify the rate of adherence of patients to AREDS 2 supplements and the factors associated with non-compliance in these patient groups.

Methods: A patient telephone survey was conducted in an Irish tertiary care hospital. Patients were identified by chart review, and their AREDS categorization was reconfirmed. A telephone consultation was conducted with each patient to assess their compliance with the micronutrient supplements.

Results: We identified 120 patients who met the AREDS criteria for supplementation. Of these, 103 patients were graded as category 4, and 17 patients were graded as category 3. Almost a fifth (18%) were current smokers. Under two-thirds (60%) of the patients were taking AREDS 2 supplements. Of the remainder, 83% of patients did not recall being advised of their benefit. The cost was cited by 10% of patients as a reason for non-compliance.

Conclusion: The ophthalmologist not only has a duty of care to treat the neovascular complications of AMD, but they must also strive to improve patient compliance with AREDS supplements. The cessation of smoking needs to be actively promoted in order to stop preventable vision loss in patients with AMD.

Keywords: Compliance; Drusen; Minerals; Neovascular AMD; Smoking; Vitamins.

PubMed Disclaimer

References

    1. Rudnicka AR, Jarrar Z, Wormald R et al (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571–580. https://doi.org/10.1016/j.ophtha.2011.09.027 - DOI - PubMed
    1. Gillies MC, Nguyen V, Daien V et al (2016) Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: data from an observational study. Ophthalmology 123:2545–2553. https://doi.org/10.1016/j.ophtha.2016.08.016 - DOI - PubMed
    1. Group A-REDSR (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436. https://doi.org/10.1001/archopht.119.10.1417 - DOI
    1. Age-Related Eye Disease Study 2 (AREDS2) (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005–2015. https://doi.org/10.1001/jama.2013.4997
    1. Hochstetler BS, Scott IU, Kunselman AR et al (2010) Adherence to recommendations of the Age-Related Eye Disease Study in patients with age-related macular degeneration. Retina 30:1166–1170. https://doi.org/10.1097/IAE.0b013e3181cea5c6 - DOI - PubMed

Substances

LinkOut - more resources